Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-03 Tax Withholding | 2024-03-04 8:54 pm | N/A N/A | TALPHERA INC. | TLPH | ASADORIAN RAFFI Chief Financial Officer | 558 | $1.3 | 37,733 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-27 9:01 pm | N/A 2034-02-13 | TALPHERA INC. | TLPH | ASADORIAN RAFFI Chief Financial Officer | 126,000 | $0 | 146,291 (Direct) | View |
| 2024-02-10 Tax Withholding | 2024-02-13 9:42 pm | N/A N/A | TALPHERA INC. | TLPH | ASADORIAN RAFFI Chief Financial Officer | 1,790 | $1.1 | 20,291 (Direct) | View |
| 2023-03-03 Tax Withholding | 2023-03-06 4:42 pm | N/A N/A | ACELRX PHARMACEUTICALS INC | ACRX | ASADORIAN RAFFI Chief Financial Officer | 510 | $1.31 | 22,081 (Direct) | View |
| 2023-02-11 Tax Withholding | 2023-02-14 4:22 pm | N/A N/A | ACELRX PHARMACEUTICALS INC | ACRX | ASADORIAN RAFFI Chief Financial Officer | 873 | $1.68 | 57,841 (Direct) | View |
| 2023-02-10 Option Award | 2023-02-14 4:22 pm | N/A 2033-02-09 | ACELRX PHARMACEUTICALS INC | ACRX | ASADORIAN RAFFI Chief Financial Officer | 41,125 | $0 | 57,841 (Direct) | View |
| 2023-02-06 Tax Withholding | 2023-02-08 4:48 pm | N/A N/A | ACELRX PHARMACEUTICALS INC | ACRX | ASADORIAN RAFFI Chief Financial Officer | 617 | $2.02 | 17,589 (Direct) | View |
| 2022-03-03 Tax Withholding | 2022-03-04 4:25 pm | N/A N/A | ACELRX PHARMACEUTICALS INC | ACRX | ASADORIAN RAFFI Chief Financial Officer | 7,923 | $0.4068 | 364,205 (Direct) | View |
| 2022-02-11 Option Award | 2022-02-14 4:50 pm | N/A 2032-02-11 | ACELRX PHARMACEUTICALS INC | ACRX | ASADORIAN RAFFI Chief Financial Officer | 352,500 | $0 | 603,080 (Direct) | View |
| 2022-02-11 Tax Withholding | 2022-02-14 4:50 pm | N/A N/A | ACELRX PHARMACEUTICALS INC | ACRX | ASADORIAN RAFFI Chief Financial Officer | 7,927 | $0.4014 | 603,080 (Direct) | View |
| 2022-02-06 Tax Withholding | 2022-02-07 7:58 pm | N/A N/A | ACELRX PHARMACEUTICALS INC | ACRX | ASADORIAN RAFFI Chief Financial Officer | 9,391 | $0.4312 | 258,515 (Direct) | View |
| 2021-03-03 Option Award | 2021-03-05 3:30 pm | N/A 2031-03-03 | ACELRX PHARMACEUTICALS INC | ACRX | ASADORIAN RAFFI Chief Financial Officer | 206,250 | $0 | 466,847 (Direct) | View |
| 2021-02-11 Tax Withholding | 2021-02-12 5:55 pm | N/A N/A | ACELRX PHARMACEUTICALS INC | ACRX | ASADORIAN RAFFI Chief Financial Officer | 9,024 | $2.63 | 183,299 (Direct) | View |
| 2021-02-06 Tax Withholding | 2021-02-09 4:33 pm | N/A N/A | ACELRX PHARMACEUTICALS INC | ACRX | ASADORIAN RAFFI Chief Financial Officer | 9,414 | $2.59 | 192,323 (Direct) | View |
| 2020-02-11 Tax Withholding | 2020-02-13 4:12 pm | N/A N/A | ACELRX PHARMACEUTICALS INC | ACRX | ASADORIAN RAFFI Chief Financial Officer | 7,924 | $1.71 | 188,765 (Direct) | View |
| 2020-02-06 Option Award | 2020-02-07 9:09 pm | N/A 2030-02-06 | ACELRX PHARMACEUTICALS INC | ACRX | ASADORIAN RAFFI Chief Financial Officer | 206,250 | $0 | 334,189 (Direct) | View |